6-Maleimidocapronic acid structure
|
Common Name | 6-Maleimidocapronic acid | ||
|---|---|---|---|---|
| CAS Number | 55750-53-3 | Molecular Weight | 211.214 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 407.3±28.0 °C at 760 mmHg | |
| Molecular Formula | C10H13NO4 | Melting Point | 86-91ºC | |
| MSDS | Chinese USA | Flash Point | 200.1±24.0 °C | |
| Symbol |
GHS05, GHS07 |
Signal Word | Danger | |
Use of 6-Maleimidocapronic acid6-Maleimidocapronic acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
| Name | 6-Maleimidocaproic Acid |
|---|---|
| Synonym | More Synonyms |
| Description | 6-Maleimidocapronic acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
|---|---|
| Related Catalog | |
| Target |
Alkyl-Chain |
| In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 407.3±28.0 °C at 760 mmHg |
| Melting Point | 86-91ºC |
| Molecular Formula | C10H13NO4 |
| Molecular Weight | 211.214 |
| Flash Point | 200.1±24.0 °C |
| Exact Mass | 211.084457 |
| PSA | 74.68000 |
| LogP | 0.71 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.537 |
| Storage condition | 2-8°C |
| Symbol |
GHS05, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H315-H318-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2925190090 |
|
~71%
6-Maleimidocapr... CAS#:55750-53-3 |
| Literature: Dalton Transactions, , # 24 p. 3886 - 3897 |
|
~74%
6-Maleimidocapr... CAS#:55750-53-3 |
| Literature: Journal of Medicinal Chemistry, , vol. 56, # 24 p. 9955 - 9968 |
|
~30%
6-Maleimidocapr... CAS#:55750-53-3 |
| Literature: EP665020 A3, ; |
|
~%
6-Maleimidocapr... CAS#:55750-53-3 |
| Literature: US8241655 B2, ; |
|
~%
6-Maleimidocapr... CAS#:55750-53-3 |
| Literature: Dalton Transactions, , # 24 p. 3886 - 3897 |
| HS Code | 2925190090 |
|---|---|
| Summary | 2925190090 other imides and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
|
An integrated microfluidic chip enabling control and spatially resolved monitoring of temperature in micro flow reactors.
Anal. Bioanal. Chem 407(2) , 387-96, (2015) A strength of microfluidic chip laboratories is the rapid heat transfer that, in principle, enables a very homogeneous temperature distribution in chemical processes. In order to exploit this potentia... |
|
|
Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport.
Exp. Cell Res. 338 , 251-60, (2015) Cellular levels of inhibitor of apoptosis (IAP) proteins are elevated in multiple human cancers and their activities often play a part in promoting cancer cell survival by blocking apoptotic pathways,... |
|
|
Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia.
Can. J. Physiol. Pharmacol. 92(12) , 1037-43, (2014) Insulin resistance, a key feature of obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM), results in a variety of metabolic and vascular abnormalities. Metabolic disturbances associated w... |
| 6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoic acid |
| MFCD00043140 |
| 1H-Pyrrole-1-hexanoic acid, 2,5-dihydro-2,5-dioxo- |
| 6-(2,5-dioxopyrrol-1-yl)hexanoic acid |